Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Bioinformatics and Experimental Validation Reveal the Mechanistic Action of Patchouli Alcohol in Prostate Cancer Treatment. | Curr Pharm Biotechnol | 2026 | 39844397 | PubTator, text mining | PubMed |
| Clinical application and drug resistance mechanism of gemcitabine. | Front Cell Dev Biol | 2025 | 41293424 | PubTator, text mining | PubMed |
| Distinct adaptive strategies to cisplatin, vinblastine and gemcitabine in a panel of chemoresistant bladder cancer cell lines. | Cancer Drug Resist | 2025 | 41019978 | PubTator, text mining | PubMed |
| Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy. | Cancers (Basel) | 2025 | 41008798 | PubTator, text mining | PubMed |
| CUB domain-containing protein 1 signaling dysregulates gemcitabine metabolism contributing to therapeutic resistance in T24 cells. | PLoS One | 2025 | 40892739 | PubTator, text mining | PubMed |
| Optimizing treatment for platinum-resistant ovarian clear cell carcinoma: Efficacy of gemcitabine and combination therapy with bevacizumab. | Cancer | 2025 | 40886107 | PubTator, text mining | PubMed |
| Viral Reprogramming of Nucleotide Synthesis and Its Impact on Viral Infection. | J Med Virol | 2025 | 40832900 | PubTator, text mining | PubMed |
| Dynamic shifts in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestation and preterm birth. | Sci Rep | 2025 | 40825832 | PubTator, text mining | PubMed |
| Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in Screening. | ACS Pharmacol Transl Sci | 2025 | 40810141 | PubTator, text mining | PubMed |
| Doxecitine and doxribtimine treatment in an adult patient with thymidine kinase 2 deficiency. | Mol Genet Metab | 2025 | 40516470 | PubTator, text mining | PubMed |
| Acquired Resistance to Decitabine Associated with the Deoxycytidine Kinase A180P Mutation: Implications for the Order of Hypomethylating Agents in Myeloid Malignancies Treatment. | Int J Mol Sci | 2025 | 40507894 | PubTator, text mining | PubMed |
| HSP90 regulates dCK stability and inhibits ionizing radiation-induced ferroptosis in cervical cancer cells. | Cell Death Discov | 2025 | 40263268 | PubTator, text mining | PubMed |
| Metabolic constraint of human telomere length by nucleotide salvage efficiency. | Nat Commun | 2025 | 40148339 | PubTator, text mining | PubMed |
| Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study. | Cancers (Basel) | 2025 | 40075743 | PubTator, text mining | PubMed |
Integrated Multi-Level Investigation of Friend Leukemia Integration 1 Transcription Factor as a Novel Immune-Inflammatory Biomarker in Rheumatoid Arthritis: Bridging Bioinformatics, Clinical Cohorts, and Mechanistic Validation. | J Inflamm Res | 2025 | 40059948 | PubTator, text mining | PubMed |
| Small-molecule inhibitor BAY synergizes with gemcitabine through AHR inhibition in pancreatic cancer cells. | Biochem Pharmacol | 2025 | 39947435 | PubTator, text mining | PubMed |
| Professional biobanking education in Korea based on ISO 20387. | J Pathol Transl Med | 2025 | 39815742 | PubTator, text mining | PubMed |
| Effects of cladribine on intrathecal and peripheral B and plasma cells. | Clin Exp Immunol | 2025 | 39663507 | PubTator, text mining | PubMed |
| Homology modelling, molecular docking studies and synthesis of aminopyrimidines as inhibitors for deoxynucleoside kinase analogues in cancer chemoprevention. | Nucleosides Nucleotides Nucleic Acids | 2025 | 39441909 | PubTator, text mining | PubMed |
| Large Language Models in Worldwide Medical Exams: Platform Development and Comprehensive Analysis. | J Med Internet Res | 2024 | 39729356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=2